Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas
about
New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in gliomaIDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma2-Hydoxyglutarate: D/Riving Pathology in gLiomaSLow rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.How molecular testing can help (and hurt) in the workup of gliomas.Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.What do we know about IDH1/2 mutations so far, and how do we use it?IDH mutations in human gliomaIDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectivesMolecular and genetic pathways in gliomas: the future of personalized therapeutics.The evolving molecular genetics of low-grade glioma.Pathology and genetics of diffuse gliomas in adults.Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.Something old and something new about molecular diagnostics in gliomas.Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
P2860
Q26863394-E9315526-70B5-4E4B-9FBD-CDF208E0FB59Q26995506-1B11E251-6574-4B65-8D80-620BBCEE9D90Q28087807-403AF61C-277D-4FDE-A371-D6A0933CF76CQ33859265-587492B9-FD9B-435D-A609-563062E8EA44Q34224704-6FF2055F-A423-4BC1-853D-F61F3098466DQ34359670-1D1B13F7-DB12-4C99-A6C7-AA3A0CB5423CQ35770275-9FDA6E1C-D78E-41C9-BD47-D121AE526B51Q36618268-2201F84A-4A44-4D3F-BFA5-3C3C99386ADEQ36788229-DD96AF25-269B-4C50-8EF5-182308AB0027Q38022856-89FA6B6E-78B6-4303-912C-B9B6C5FEC2A0Q38052534-34A5CF74-E8E8-4395-B937-C5194AAB28B9Q38233171-B5D0E06A-8595-4BA1-BCA7-2B694F15AFE4Q38349169-1BD9F590-3FB0-4CF6-9E24-BAEA25EFC138Q38368235-5FF4937C-71D6-49FA-AD87-40C3B8E5141BQ38627095-CC5228D0-A9D2-464F-BBB3-4A26794F3298Q43238974-69697F71-54D6-4CAD-BB0A-FD855479043FQ44649106-DF14F667-8D51-4DB5-8AC2-F3992D4E3676
P2860
Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Isocitrate dehydrogenase 1 ana ...... omas from infiltrative gliomas
@en
type
label
Isocitrate dehydrogenase 1 ana ...... omas from infiltrative gliomas
@en
prefLabel
Isocitrate dehydrogenase 1 ana ...... omas from infiltrative gliomas
@en
P2093
P2860
P1433
P1476
Isocitrate dehydrogenase 1 ana ...... omas from infiltrative gliomas
@en
P2093
Craig Horbinski
David N Louis
Gabrielle Yeaney
Geoffrey Murdoch
Julia Kofler
Marina Nikiforova
Sandra Camelo-Piragua
Sriram Venneti
P2860
P304
P356
10.1111/J.1750-3639.2011.00480.X
P50
P577
2011-03-14T00:00:00Z